Chronic hemolysis, with consequent hyperbilirubinemia, predisposes SS patients to pigment gallstones. The other factors which influence the development of stones in these patients have not been identified. We have carried out a combined prospective and retrospective study of SS patients in Kuwait and specifically investigated the influence of coexistent α-thal trait on the prevalence of gallstones. A total of 45 patients (30 males, 15 females) with ages ranging from 1 to 16 years (mean 7.2 ± 3.1) were studied. Most were either homozygotes for the Saudi Arabia/India haplotype (86.7%) or compound heterozygotes for this and the Benin haplotype (11.1%). They were screened for gallstones with ultrasonography. α-Globin genotypes were determined using a combination of PCR and allele-specific oligonucleotide hybridization techniques to identify the common α-thalassemia alleles in this population. Gallstones were detected in 7 (15.6%) patients (4 males, 3 females), whose mean age (10.5 ± 5.5 years) was significantly higher than that (6.8 ± 3.2 years) of those without stones (p < 0.01). The mean total Hb of the former (8.4 ± 0.8 g/dl) was also significantly (p < 0.05) lower than in the latter (9.5 ± 1.3 g/dl), while the difference in mean Hb F levels was not significant. None of the 4 α-thal homozygotes had gallstones while 2 of 13 heterozygotes and 5 of the 23 patients without coexistent α-thal had. The differences in these proportions are statistically significant (χ2 = 20.4, p < 0.001). It therefore appears that coexistent α-thal decreases the chance of developing gallstones in Arab SS patients. This may be related to less hemolysis in such patients as shown by their higher mean Hb level.

Keywords:
α-Thalassemia, Cholelithiasis, Gallstones, Sickle cell anemia
1.
Miller BA, Olivieri N, Salameh M, Ahmed M, Antognetti G, Huisman THJ, Nathan DG, Orkin SH: Molecular analysis of the high-hemoglobin F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med 1987;316:244–250.
2.
Powars DR: Sickle cell anemia: βS-globin gene cluster haplotypes as prognostic indicators of vital organ damage. Semin Hematol 1991;28:202–208.
3.
Adekile AD: Historical and anthropological correlates of βS haplotypes and α- and β-thalassemia alleles in the Arabian Peninsula. Hemoglobin 1997;21:281–296.
4.
Adekile AD, Haider MZ: Morbidity, βS haplotype and α-globin gene patterns in SS patients from Kuwait. Acta Haematol 1996;96:150–154.
5.
Nagel RL: Severity pathobiology, epistatic effect and genetic markers in sickle cell anemia. Semin Hematol 1991;28:180–201.
6.
Mears JG, Lachman HM, Labie D, Nagel RL: α-Thalassemia is related to prolonged survival in sickle cell anemia. Blood 1983;62:286–290.
7.
Steinberg MH, Rosenstock W, Coleman MB, Adams JG, Platica O, Cedeno M, Rieder RF, Wilson JT, Milner P, West S, and the Cooperative Study of Sickle Cell Disease: Effects of thalassemia and microcytosis on the hematologic and vaso-occlusive severity of sickle cell anemia. Blood 1984;63:1353–1360.
8.
Adekile AD, Tuli M, Haider MZ, Al-Zaabi K, Al-Mohannadi S, Owunwanne O: Influence of α-thalassemia trait on spleen function in sickle cell anemia patients with high Hb F. Am J Hematol 1996;53:1–5.
9.
Lachman BS, Lazerson J, Starshak RJ, Vaughters FM, Werlin SL: The prevalence of cholelithiasis in sickle cell disease as diagnosed by ultrasonography and cholecystography. Pediatrics 1979;64:601–603.
10.
Sarnaik S, Slovis TH, Corbett DP, Emami A, Whitten CF: Incidence of cholelithiasis in sickle cell anemia using the ultrasonic gray-scale technique. J Pediatr 1980;96:1005–1008.
11.
Rutledge RT, Croom RD, David JW, Berkowitz LR, Orringer EP: Cholelithiasis in sickle cell anemia: Surgical considerations. South Med J 1986;79:28–32.
12.
Al-Salem AH, Jaber A, Abu-Srair H, Al-Jama A, Al-Jishi N: Cholelithiasis in Saudi patients with sickle cell anemia. Ann Saudi Med 1992;12:387–390.
13.
Righetti PG: Practical application of isoelectric focusing in hemoglobin separation and identification; in Huisman THJ (ed): The Hemoglobinopathies. Methods in Hematology Series. Edinburgh, Churchill Livingstone, 1986, vol 15, pp 47–70.
14.
Bissé E, Wieland H: High-performance liquid chromatographic separation of human haemoglobins. Simultaneous quantitation of foetal and glycated haemoglobins. J Chromatogr 1988;434:95–110.
15.
Kutlar A, Kutlar F, Gu L-G, Mayson SM, Huisman THJ: Fetal hemoglobin in normal adults and β-thalassemia heterozygotes. Hum Genet 1990;85:106–110.
16.
Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S: Construction of human gene libraries from small amounts of peripheral blood: Analysis of β-like globin genes. Hemoglobin 1982;6:27–36.
17.
Dimovski AJ, Oner C, Agarwal S, Gu Y-C, Kutlar F, Lanclos KD, Huisman THJ: Certain mutations observed in the 5′ sequences of the Gγ- and Aγ-globin genes of βS chromosomes are specific for chromosomes with major haplotypes. Acta Haematol 1991;85:79–87.
18.
Lanclos KD, Oner C, Dimovski AJ, Gu Y-C, Huisman THJ: Sequence variations of the 5′ flanking and IVS-II regions of the Gγ- and Aγ-globin genes of βS chromosomes with five different haplotypes. Blood 1991;77:2488–2496.
19.
Baysal E, Huisman THJ: Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol 1994;46:208–213.
20.
Adekile AD, Gu L-H, Baysal E, Haider MZ, Al-Fuzae L, Aboobacker KC, Al-Rashied A, Huisman THJ: Molecular characterization of α-thalassemia determinants, β-thalassemia alleles, and βS haplotypes among Kuwaiti Arabs. Acta Haematol 1994;92:176–181.
21.
Steinberg MH: Modulation of the phenotypic diversity of sickle cell anemia. Hemoglobin 1996;20:1–19.
22.
Gupta AK, Kirchner KA, Nicholson R, Adams JG, Steinberg MH: Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait. J Clin Invest 1991;88:1963–1968.
23.
Embury SH: The interaction of α-thalassemia with sickle cell anemia. Hemoglobin 1988;12:509–512.
24.
Adams RJ, Kutlar A, McKie V, Carl E, Nichols FT, Liu JC, McKie K, Clary AL: Alpha-thalassemia and stroke risk in sickle cell anemia. Am J Hematol 1994;45:279–282.
25.
Adekile AD, Makanjuola DI: Real-time gallbladder ultrasonography in children with sickle cell anaemia. Niger J Paediatr 1983;10:35–38.
26.
Adekile AD: Experience with cholelithiasis in Nigerian sickle cell patients. Am J Pediatr Hematol Oncol 1985;7:261–264.
27.
Nzeh DA, Adedoyin MA: Sonographic pattern of gallbladder disease in children with sickle cell anaemia. Pediatr Radiol 1989;19:290–292.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.